Aptamer‐protac conjugates (apcs) for tumor‐specific targeting in breast cancer
S He, F Gao, J Ma, H Ma, G Dong… - Angewandte …, 2021 - Wiley Online Library
Abstract Development of proteolysis targeting chimeras (PROTACs) is emerging as a
promising strategy for targeted protein degradation. However, the drug development using …
promising strategy for targeted protein degradation. However, the drug development using …
Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer
S He, F Gao, J Ma, H Ma, G Dong… - Angewandte Chemie …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Development of proteolysis targeting chimeras
(PROTACs) is emerging as a promising strategy for targeted protein degradation. However …
(PROTACs) is emerging as a promising strategy for targeted protein degradation. However …
Aptamer‑PROTAC Conjugates (APCs) for Tumor‑Specific Targeting in Breast Cancer
S He, F Gao, J Ma, H Ma, G Dong… - Angewandte …, 2021 - ui.adsabs.harvard.edu
Abstract Development of proteolysis targeting chimeras (PROTACs) is emerging as a
promising strategy for targeted protein degradation. However, the drug development using …
promising strategy for targeted protein degradation. However, the drug development using …
Aptamer-PROTAC Conjugates (APCs) for Tumor-specific Targeting in Breast Cancer
S He, F Gao, J Ma, H Ma, G Dong, C Sheng - paper.sciencenet.cn
Development of proteolysis targeting chimeras (PROTACs) is emerging as a promising
strategy for targeted protein degradation. However, the drug development using the …
strategy for targeted protein degradation. However, the drug development using the …
Aptamer-PROTAC Conjugates (APCs) for Tumor-Specific Targeting in Breast Cancer.
S He, F Gao, J Ma, H Ma, G Dong… - … Chemie (International ed …, 2021 - europepmc.org
Development of proteolysis targeting chimeras (PROTACs) is emerging as a promising
strategy for targeted protein degradation. However, the drug development using the …
strategy for targeted protein degradation. However, the drug development using the …
Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer.
S He, F Gao, J Ma, H Ma, G Dong… - Angewandte …, 2021 - search.ebscohost.com
Abstract Development of proteolysis targeting chimeras (PROTACs) is emerging as a
promising strategy for targeted protein degradation. However, the drug development using …
promising strategy for targeted protein degradation. However, the drug development using …
Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast Cancer
S He, F Gao, J Ma, H Ma, G Dong… - Angewandte Chemie …, 2021 - Wiley Online Library
Abstract Development of proteolysis targeting chimeras (PROTACs) is emerging as a
promising strategy for targeted protein degradation. However, the drug development using …
promising strategy for targeted protein degradation. However, the drug development using …
Aptamer-PROTAC Conjugates (APCs) for Tumor-Specific Targeting in Breast Cancer
S He, F Gao, J Ma, H Ma, G Dong… - … (International ed. in …, 2021 - pubmed.ncbi.nlm.nih.gov
Development of proteolysis targeting chimeras (PROTACs) is emerging as a promising
strategy for targeted protein degradation. However, the drug development using the …
strategy for targeted protein degradation. However, the drug development using the …